Letter to the Editor: "Association between metformin and survival outcomes in in-hospital cardiac arrest patients with diabetes".

Honoré, Patrick;Bousbiat, Ibrahim;Perriens, Emily;Blackman, Sydney
(2023) Journal of Critical Care — Vol. 78, p. 154347 [1-2] (2023)

Files

HonorePCritCare2023.pdf
  • Open Access
  • Adobe PDF
  • 285.49 KB

Details

Authors
  • Author
  • Bousbiat, Ibrahim
    Author
  • Perriens, Emily
    Author
  • Blackman, Sydney
    Author
Abstract
(en) With great interest, we read the recently published article by Jin, et al. who conclude that administration of 500–1000 mg/day metformin resulted in a better survival to discharge rate than administration of other doses of metformin [1]. In addition, as the time interval from administration of metformin before intra-hospital cardiac arrest (IHCA) increased, the rate of survival to discharge showed a decreasing trend. The patients who administered metformin within 6 h, the half- life of metformin, before IHCA and 6–12 h before IHCA had better survival rates than those who did not. [...]
Affiliations

Citations

Honoré, P., Bousbiat, I., Perriens, E., & Blackman, S. (2023). Letter to the Editor: “Association between metformin and survival outcomes in in-hospital cardiac arrest patients with diabetes”. Journal of Critical Care, 78, 154347 [1-2]. https://doi.org/10.1016/j.jcrc.2023.154347 (Original work published 2023)